Utah Medical Products, Inc. (NASDAQ:UTMD), declared a quarterly dividend on Wednesday, May 7th, AnalystRatingsNetwork reports. Stockholders of record on Wednesday, June 18th will be given a dividend of 0.25 per share on Thursday, July 3rd. This represents a $1.00 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date of this dividend is Monday, June 16th. Utah Medical Products, Inc. (NASDAQ:UTMD), net profit margin is 35.60% and weekly performance is -0.38%. On last trading day company shares ended up $47.37. Utah Medical Products, Inc. (NASDAQ:UTMD), distance from 50-day simple moving average (SMA50) is -9.75%.
Covidien plc (NYSE:COV), had its price target upped by Needham & Company LLC from $77.00 to $80.00 in a research note issued to investors on Friday, Analyst Ratings.Net reports. Covidien plc (NYSE:COV), advanced 0.24% in last trading session and ended the day on $71.19. COV, Gross Margin is 58.80% and its return on assets is 8.00%. Covidien plc (NYSE:COV), quarterly performance is 0.96%.
Merit Medical Systems, Inc. (NASDAQ:MMSI), CFO Kent Stanger sold 22,259 shares of the company’s stock in a transaction dated Wednesday, May 21st. The stock was sold at an average price of $14.00, for a total value of $311,626.00. Following the sale, the chief financial officer now directly owns 714,836 shares of the company’s stock, valued at approximately $10,007,704. Merit Medical Systems, Inc. (NASDAQ:MMSI), shares moved down 0.14% in last trading session and was closed at $14.03, while trading in range of $13.95 – 14.12. Merit Medical Systems, Inc. (NASDAQ:MMSI), year to date (YTD) performance is -10.86%.
On May 13, 2014, Yacktman sees unrecognized value in C.R. Bard, Inc. (NYSE:BCR), as a result from a lawsuit that was settled in Bard’sfavor. The company has been reinvesting the proceeds, giving it an edge against others in the industry. C.R. Bard, Inc. (NYSE:BCR), ended the last trading day at $146.62. Company weekly volatility is calculated as 1.20% and price to cash ratio as 11.90. C.R. Bard, Inc. (NYSE:BCR), showed a negative weekly performance of 1.28%.
On May 19, 2014, The Female Health Company (NASDAQ:FHCO), announced a repurchase of 35,000 shares of its outstanding common stock under the Company’s stock repurchase program. The program has a repurchase cap of three million shares of common stock and expires on December 31, 2014. The Company has repurchased approximately 2.1 million shares under the program, and approximately 0.9 million shares remain for potential repurchase. The Female Health Company (NASDAQ:FHCO), net profit margin is 39.80% and weekly performance is 0.85%. On last trading day company shares ended up $5.95. The Female Health Company (NASDAQ:FHCO), distance from 50-day simple moving average (SMA50) is -15.84%.